Search

Author/Creator Merlo, D.F.

1. 3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine. (September 2015)

Authors:
Queirolo, P.; Spagnolo, F.; Picasso, V.; Simeone, E.; Grimaldi, A.M.; Curvietto, M.; Giorello, L.; Fontana, V.; Merlo, D.F.; Ascierto, P.A.; Bruzzi, P.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S683
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search